Results 311 to 320 of about 1,184,339 (384)

Annual Banned‐Substance Review 17th Edition—Analytical Approaches in Human Sports Drug Testing 2023/2024

Drug Testing and Analysis, EarlyView.
Scenarios of drug exposure and administration as well as detection assays for drugs and methods of sports doping published between 2023 and 2024 are critically reviewed and evaluated in context with the Prohibited List 2024 as established by the World Anti‐Doping Agency.
Mario  Thevis, Tiia  Kuuranne, Hans  Geyer   +2 more
wiley   +1 more source

Unravelling the Mechanisms of Oxidised Low-Density Lipoprotein in Cardiovascular Health: Current Evidence from In Vitro and In Vivo Studies. [PDF]

Int J Mol Sci
Thangasparan S, Kamisah Y, Ugusman A, Mohamad Anuar NN, Ibrahim N'.   +4 more
europepmc   +1 more source

Additional role of low-density lipoprotein cholesterol on the risk of osteoporosis in men with or without coronary heart disease: a real-world longitudinal study. [PDF]

J Geriatr Cardiol
Zeng J, Pan ZM, Li T, Chen ZY, Cai XY, Gong ML, Deng XL, Wang SS, Li N, Liu M, Li CL.   +10 more
europepmc   +1 more source

Aggressive low-density lipoprotein (LDL) lowering for primary prevention: still an elusive goal. [PDF]

Lipids Health Dis
Sepehrinia M, Homayounfar R, Farjam M.
europepmc   +1 more source

Low-Density Lipoprotein Receptor Apolipoprotein B Gene Polymorphism in Kurdish Patients With Severe Hypercholesterolemia. [PDF]

Cureus
Sabri S, Salih S, Al-Timimi D.
europepmc   +1 more source

Correction to "Tumor-Activatable Nanoparticles Target Low-Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy". [PDF]

Adv Sci (Weinh)
europepmc   +1 more source

Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and Mortality in China.

JAMA Netw Open
Chen L, Chen S, Bai X, Su M, He L, Li G, He G, Yang Y, Zhang X, Cui J, Xu W, Song L, Yang H, He W, Zhang Y, Li X, Hu S.   +16 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Low density lipoprotein

Springer Reference Medizin, 2018
D. Peetz, K. J. Lackner
openaire   +3 more sources

Electronegative low-density lipoprotein

Current Opinion in Lipidology, 2004
The occurrence in blood of an electronegatively charged LDL was described in 1988. During the 1990s reports studying electronegative LDL (LDL(-)) were scant and its atherogenic role controversial. Nevertheless, recent reports have provided new evidence on a putative atherogenic role of LDL(-).
Jordi Ordóñez-Llanos, José Luis Sánchez-Quesada, Sonia Benitez   +2 more
openaire   +3 more sources

Evaluation of Malondialdehyde Low-Density Lipoprotein Stratified by Low-Density Lipoprotein Cholesterol

Clinical Laboratory, 2017
Malondialdehyde low-density lipoprotein (MDA-LDL) is a major form of oxidized LDL and considered to be more atherogenic than LDL. Information on major determinants of MDA-LDL and their association in subjects who are not under treatment for diabetes mellitus and dyslipidemia is limited.This study included 778 Japanese subjects who were not taking ...
Kengo Moriyama, Eiko Takahashi
openaire   +3 more sources